U.S. President Donald Trump signed a wide-reaching executive order on Monday directing drugmakers to lower the prices of ...

Drugmakers have long argued that any threats to their profits could impact the research they do to develop new drugs.

By Steve Holland, Michael Erman and Patrick Wingrove WASHINGTON (Reuters) -U.S. President Donald Trump signed a wide-reaching ...

AI adoption in pharma can be slow, but failing to scale these new tools across your organization is a missed opportunity.

The president is planning Monday to revive a plan from his first term, which would peg the prices the United States pays for ...

Tucked inside Trump's drug-pricing executive order is an apparent threat to withdraw drugmakers' medicines if they do not ...

The pharmaceutical industry has argued that Trump’s 2020 attempt would give foreign governments the “upper hand” in deciding the value of medicines in the U.S.

By Chioma Obinna The Director-General of the National Agency for Food and Drug Administration and Control, NAFDAC, Prof ...

Tucked inside President Trump's executive order on drug pricing is a sentence that appears to threaten the FDA could yank ...

President Trump's executive order on drug pricing caused a surprising rally in pharmaceutical stocks. Read my analysis of PJP ...

RFK Jr. told Americans President Trump cannot be bought while also revealing Trump accepted $100 million from Big Pharma.